Osteopore Ltd. (AU:OSX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Osteopore Limited (ASX:OSX) has achieved its seventh consecutive quarter of revenue growth, reporting a 29% year-on-year increase for Q3 CY24. The company has also signed an exclusive distribution agreement with Zimmer Biomet to expand its craniofacial products in EMEA and APAC regions. Additionally, Dr. Yujing Lim has been appointed as Executive Director, strengthening Osteopore’s leadership team.
For further insights into AU:OSX stock, check out TipRanks’ Stock Analysis page.